Hereditary breast cancer follows an autosomal dominant inheritance pattern, meaning you only need to inherit one copy of a mutated gene from one parent to have a significantly elevated risk. But this answer comes with an important nuance: dominant inheritance here means a dominant risk of developing cancer, not a guarantee. And the vast majority of breast cancers, around 90 to 95 percent, aren’t inherited at all.
What “Dominant” Actually Means Here
When geneticists call hereditary breast cancer “dominant,” they mean the mutation follows you through a family tree the way a dominant trait would. If one of your parents carries a harmful change in a gene like BRCA1 or BRCA2, you have a 50 percent chance of inheriting that same change. If you do inherit it, your lifetime risk of breast cancer rises dramatically: more than 60 percent for women, compared to about 13 percent in the general population. You don’t need both parents to pass along the mutation for the risk to increase.
This is different from a recessive condition, where you’d need two copies of a faulty gene (one from each parent) before it affects you. With BRCA mutations, a single copy is enough to put you at high risk. Hereditary breast and ovarian cancer syndrome, caused by BRCA1 and BRCA2 mutations, accounts for roughly half of all genetically linked breast cancer cases.
Why It Acts Recessive Inside Your Cells
Here’s where the biology gets more interesting. Even though the inheritance pattern looks dominant in a family tree, what happens inside individual cells is actually recessive. This concept, known as the “two-hit hypothesis,” was developed by geneticist Alfred Knudson and is central to understanding how these cancers form.
Everyone carries two copies of genes like BRCA1 and BRCA2. If you inherit one faulty copy, your cells still have one working copy acting as a backup. That working copy keeps producing the proteins that repair damaged DNA and suppress tumor growth. Cancer doesn’t develop until the second, healthy copy is also knocked out by a random mutation that occurs during your lifetime. This loss of the backup copy is called “loss of heterozygosity.”
So the pattern is dominant at the family level (one mutated copy is enough to elevate risk) but recessive at the cellular level (both copies must fail before a tumor forms). People who inherit one damaged copy simply have a head start toward cancer because they only need one more “hit” instead of two. That’s why the risk is high but not 100 percent.
Genes Beyond BRCA1 and BRCA2
BRCA1 and BRCA2 get the most attention, but several other genes also follow autosomal dominant inheritance and raise breast cancer risk. These are grouped by how strongly they influence risk.
- High-penetrance genes (TP53, CDH1, PTEN, STK11) can push lifetime breast cancer risk as high as 80 percent. Mutations in CDH1 carry a 39 percent lifetime risk. PTEN mutations, which cause Cowden Syndrome, carry a 25 to 50 percent lifetime risk. STK11 mutations bring a 32 to 54 percent probability, typically showing up around age 39.
- Moderate-penetrance genes (CHEK2, PALB2, ATM, BRIP1) roughly double to quadruple the risk. PALB2 mutations increase risk two to threefold, with a cumulative risk around 35 percent. CHEK2 carriers without affected relatives face about a 20 percent risk, climbing to 44 percent if close family members also have breast cancer. ATM mutations are linked to a two to fourfold increase.
Together, high-penetrance genes account for up to 25 percent of hereditary breast cancers, while moderate-penetrance genes contribute another 2 to 3 percent. All of these follow dominant inheritance, meaning one mutated copy from one parent is sufficient to raise your risk.
There is at least one notable exception. A gene called MUTYH operates recessively, requiring mutations in both copies before it affects function. MUTYH is primarily associated with a type of colon polyp syndrome, but it illustrates that not every cancer-related gene follows the same inheritance rules.
Inherited vs. Sporadic Breast Cancer
Only about 5 to 10 percent of all breast cancers are hereditary, meaning they result from gene mutations passed down through families. The remaining 90 to 95 percent are sporadic, caused by DNA damage that accumulates during a person’s lifetime rather than something inherited at birth. These sporadic mutations happen randomly in breast cells and can’t be passed to children.
The distinction matters because it shapes what the word “dominant” means in practice. When someone asks whether breast cancer is dominant or recessive, the answer applies only to the hereditary fraction. Most breast cancers have no inherited genetic cause at all, and the people who develop them may have no family history of the disease.
That said, the hereditary percentage is higher in younger women. Genetic factors may account for about 25 percent of breast cancers diagnosed in women under 30, making family history a more significant factor in early-onset cases.
How This Applies to Men
Men can also inherit BRCA mutations and develop breast cancer, though it’s far less common. Men with a BRCA2 mutation face about a 6 percent lifetime risk of breast cancer, while those with a BRCA1 mutation have roughly a 1 percent risk. In the general male population, the baseline risk is about 0.1 percent by age 70.
Because the inheritance is autosomal (carried on a non-sex chromosome) and dominant, men and women inherit these mutations at equal rates. A father with a BRCA2 mutation has the same 50 percent chance of passing it to a son as to a daughter. Men who carry the mutation often don’t develop breast cancer themselves but can still pass the elevated risk to their children.
What Dominant Inheritance Means for Families
If a parent carries a dominant breast cancer gene mutation, each child has a coin-flip chance of inheriting it, regardless of sex. This is why hereditary breast cancer often appears in multiple generations, sometimes alternating between breast, ovarian, and other related cancers depending on which gene is involved.
Carrying the mutation doesn’t mean cancer is inevitable. Penetrance, the percentage of carriers who actually develop cancer, varies by gene. BRCA1 and BRCA2 have high penetrance (over 60 percent for female breast cancer), while moderate-penetrance genes may only double your baseline risk. Factors like the specific location of the mutation within the gene, lifestyle, hormonal history, and other genetic variations all influence whether a carrier ultimately develops cancer.
Genetic testing can identify whether you carry one of these dominant mutations. Testing is typically recommended if you have a strong family history: multiple relatives with breast or ovarian cancer, cancer diagnosed before age 50, or male relatives with breast cancer. Knowing your status opens up options for earlier and more frequent screening, preventive medications, or risk-reducing surgery.